Section Arrow
Quote
MGTX.NASDAQ
- MeiraGTx Holdings plc
Quotes are at least 15-min delayed:2026/07/17 06:02 EDT
Pre Market
Last
 12.33
0 (0.00%)
Bid
4.99
Ask
14.8
High 12.53 
Low 12.33 
Volume 78 
Regular Hours (Closed)
Last
 12.33
-0.23 (-1.83%)
Day High 
12.5199 
Prev. Close
12.56 
1-M High
15.35 
Volume 
563.37K 
Bid
4.99
Ask
14.8
Day Low
12.09 
Open
12.38 
1-M Low
9.51 
Market Cap 
1.16B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 13.41 
20-SMA 12.51 
50-SMA 10.77 
52-W High 15.35 
52-W Low 6.62 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.48/-0.17
Enterprise Value
1.22B
Balance Sheet
Book Value Per Share
-0.63
Cash Flow
Cash Flow Yield
0.01
Income Statement
Total Revenue
81.39M
Operating Revenue Per Share
0.07
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
LIMNLiminatus Pharma Inc0.1477+0.0332+29.00%-- 
Pre Market 0.1263 -0.0214 -14.49%
ATAIAtaiBeckley Inc7.15+1.79+33.40%-- 
Pre Market 7.08 -0.07 -0.98%
KAPAKairos Pharma Ltd.0.3399+0.0219+6.89%-- 
Pre Market 0.2861 -0.0538 -15.83%
RXRXRecursion Pharmaceuticals3.02-0.29-8.76%-- 
Pre Market 2.97 -0.05 -1.66%
IOVAIovance Biotherapeutics4.66-0.08-1.69%-- 
Pre Market 4.6009 -0.0591 -1.27%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.